Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4582246
Max Phase: Preclinical
Molecular Formula: C31H39N7O3
Molecular Weight: 557.70
Molecule Type: Unknown
Associated Items:
ID: ALA4582246
Max Phase: Preclinical
Molecular Formula: C31H39N7O3
Molecular Weight: 557.70
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN[C@@H](C)C(=O)N[C@H]1CCCC[C@H]2CC[C@@H](C(=O)N[C@@H](c3ccccc3)c3cn(Cc4ccccc4)nn3)N2C1=O
Standard InChI: InChI=1S/C31H39N7O3/c1-21(32-2)29(39)33-25-16-10-9-15-24-17-18-27(38(24)31(25)41)30(40)34-28(23-13-7-4-8-14-23)26-20-37(36-35-26)19-22-11-5-3-6-12-22/h3-8,11-14,20-21,24-25,27-28,32H,9-10,15-19H2,1-2H3,(H,33,39)(H,34,40)/t21-,24-,25-,27-,28-/m0/s1
Standard InChI Key: PQQUWWCKZXWSKC-JSTXPWCMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 557.70 | Molecular Weight (Monoisotopic): 557.3114 | AlogP: 2.56 | #Rotatable Bonds: 9 |
Polar Surface Area: 121.25 | Molecular Species: BASE | HBA: 7 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.94 | CX Basic pKa: 8.60 | CX LogP: 2.98 | CX LogD: 1.76 |
Aromatic Rings: 3 | Heavy Atoms: 41 | QED Weighted: 0.37 | Np Likeness Score: -0.95 |
1. Cong H, Xu L, Wu Y, Qu Z, Bian T, Zhang W, Xing C, Zhuang C.. (2019) Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives., 62 (12): [PMID:30676015] [10.1021/acs.jmedchem.8b01668] |
Source(1):